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SpermatogenesisThere is an association between hypertension and reproductive dysfunction. Angiotensin II (Ang II) is involved in
the pathogenesis of hypertension and the regulation of reproduction. The present study aimed to determine
whether the angiotensinergic system mediates the effects of hypertension on reproductive function in male
rats subjected to a two-kidney, one-clip (2K1C) model. Sexual behavior parameters, gametogenesis and plasma
concentrations of Ang II, testosterone, prolactin and corticosterone were evaluated in male rats 28 days after
2K1C or sham surgery and losartan (Los) treatment (a type 1 angiotensin II (AT1) receptor antagonist) or vehicle
(V) treatment. The animals were divided into Sham+V, 2K1C+V, Sham+Los and 2K1C+Los groups. The
2K1C+V group showed a hypertensive response, inhibition of sexual behavior, spermatogenesis dysfunction,
and increases in plasma Ang II and prolactin. Conversely, plasma testosterone decreased, and plasma corticoste-
rone remained constant. Losartan treatment normalized blood pressure and prevented the changes in plasma
testosterone and prolactin, sexual behavior and spermatogenesis in the 2K1C+Los group. In addition, losartan
treatment caused an additional increase in circulating Ang ll in both groups (Sham+Los and 2K1C+Los). To-
gether, these results suggest that Ang ll, acting through the AT1 receptor, modulates behavioral and endocrine
parameters of reproductive function during renovascular hypertension. In addition, the effects of circulating
Ang II on plasma testosterone and prolactin seem to contribute to the spermatogenic and sexual dysfunctions
in hypertensive rats.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Normal reproductive function requires the integration of several
physiological mechanisms, involving the central and peripheral ner-
vous systems, cardiovascular system, pituitary, and reproductive organs
(Speth et al., 1999). Chronic high blood pressure can cause progressive
damage to the arterial vessels, brain, heart, kidney, and sex organs.
Hypertension is a risk factor for sexual dysfunction in males (Manolis
andDoumas, 2008). However, themechanisms underlying reproductive
dysfunction associated with hypertension remain poorly understood.
Angiotensin II (Ang II) is a peptide that plays an important role in the
pathogenesis of hypertension (Fitzsimons, 1980; Reid et al., 1978) and
is also involved in the regulation of reproduction function (Ganong,
1995). Central Ang ll has an inhibitory role in the modulation of sexual
behavior inmale rats (Clark, 1988). Our laboratory reported thatmicro-
injection of Ang II into the medial amygdaloid nucleus decreases sexual
behavior in male rats (Breigeiron et al., 2002). Peripherally, Ang IIcrinologia do Comportamento,
sicas da Saúde, Universidade
e 500, Porto Alegre, Rio Grande
eissheimer).
vier OA license.affects testicular function, modifying seminiferous tubule contraction
(Rossi et al., 2002), and could be involved in the inhibition of spermato-
genesis. Male rats subjected to the two-kidney, one-clip model (2K1C)
exhibit reproductive hormone and sexual behavior changes and im-
paired spermatogenesis. The treatment of hypertensive rats with nifed-
ipine, a Ca++ channel blocker, prevents the increases in blood pressure
and plasma prolactin, as well as the decrease in sexual behavior. How-
ever, the impairment of spermatogenesis and reductions of plasma
testosterone and FSH are not prevented by nifedipine (Breigeiron et al.,
2007). Therefore, the mechanisms underlying reproductive dysfunction
associated with renovascular hypertension remain to be clariﬁed.
The effects of Ang II on cardiovascular and reproductive functions
are mainly mediated through Ang II type 1 (AT1) receptor (Chan
et al., 1999; Keaton and Clark, 1998). Therefore, speciﬁc AT1 antagonists
are potentially useful for treating hypertension (Chiu et al., 1990;
Tsunoda et al., 1993) and for improving sexual dysfunction in hyperten-
sive patients (Della Chiesa et al., 2003). Ang II can modulate reproduc-
tive function by affecting the expression of hormonal regulators of
reproduction or stress, such as gonadotropins, prolactin, and corticoste-
rone (Donadio et al., 2004; Dornelles and Franci, 1998; Ganong, 1995;
Rivier and Vale, 1983). However, effects of the interactions among
Ang II and these hormones on reproduction need to be better
investigated.
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(2K1C) and the AT1 receptor antagonist losartan to analyze the role
of the angiotensinergic system as a mediator of the effects of hyper-
tension on reproductive function in male rats. Considering that Ang
II is involved in hypertension and in the regulation of reproductive
function, we hypothesize that Ang II, as mediated by AT1 receptor,
can play an inhibitory role in sexual behavior and spermatogenesis.
Materials and methods
All procedures used in this study followed the guidelines for the
care and use of Laboratory Animals from the National Institutes of
Health and were approved by the Ethics Committee in Research of
the Federal University of Rio Grande do Sul (Protocol # 13434).
Animals and general procedure
Three-month-old Wistar rats were obtained from the colony main-
tained in the Federal University of Rio Grande do Sul Laboratory Animal
Facility. Animals were kept on a 12 h light/dark cycle (lights off at
6:00 PM) and in a stable environmental temperature (21 °C) with ad
libitum access to rat chow (Nutrilab, Colombo, Brazil) and water. On
the night before surgical procedures, male rats were selected for sexual
behavior analysis, and only those with at least 6 intromission behaviors
in a 10 min test were used. Male sexual behavior was recorded 28 days
after sham or 2K1C surgery, at night before decapitation. The systolic
bloodpressurewas recorded themorning following the sexual behavior
test, 4–5 h before sacriﬁce. Immediately after decapitation, the blood
was collected for hormone assays, and the testes were excised,
weighed, and frozen for later spermatogenesis analysis.
Three-month-old female Wistar rats were used to record male
sexual behavior. The females were gonadectomized and induced to
sexual receptiveness by a sequential subcutaneous injection of 20 μg
of estradiol (Benzo-ginoestril, Sanoﬁ, São Paulo, Brazil) 48 h before
testing and 20 μg of estradiol plus 500 μg of progesterone (4-Pregnene-
3,20-dione, Sigma, St. Louis, MO, USA) 6 h before testing. All females
were ﬁrst tested with nonexperimental, sexually active males, and
only females that were receptive (lordotic) were used.
Experimental groups
Male rats were divided into 4 groups: sham surgery with vehicle
(water) (Sham+V; n=11), 2K1C surgery with vehicle (water)
(2K1C+V; n=11), sham surgery with losartan treatment (Sham+
Los; n=11), and 2K1C surgery with losartan treatment (2K1C+Los;
n=11).
Surgical procedures
The 2K1C model was employed in male rats weighing 290 to 330 g
(n=22). These animals were anesthetized with i.p. administration of
a ketamine–xylazine cocktail (100 mg/kg of ketamine and 50 mg/kg
of xylazine; Syntec, São Paulo, Brazil) for the surgical procedures.
The left renal artery was isolated, and a small segment was dissected
free of the renal vein to place a silver clip (internal diameter
0.23 mm) around the main renal artery. As controls, sham-operated
rats (n=22) underwent the same surgical procedure without receiv-
ing the clip.
Losartan treatment
The dose of losartan was determined according to the ﬁndings of a
previous study (Nobre et al., 2006). Losartan (DUP 753, Du Pont, DE,
USA) was dissolved in the drinking water of the 2K1C and sham
rats for 21 days before decapitation. Seven days after surgery, when
animals were recovered from surgery, systolic blood pressure wasrecorded in 2K1C and sham rats. All normotensive sham rats received
losartan treatment, but in the 2K1C group, only hypertensive animals
received this treatment. The losartan dose (10 mg/kg/day) was adjust-
ed according to each rat's water intake and body weight previously
established in our laboratory. Solutions with losartan were changed
every 24 h to measure the volume (in mL) that was drunk per day by
each rat.
Arterial pressure recording
Systolic blood pressure (SBP) was indirectly measured (tail-cuff
method) with a pressure transducer connected to a Kent Scientiﬁc
system (RTBP 1001 Rat Tail Blood Pressure System; Litchﬁeld, USA).
Recordings were quantiﬁed using WinDaq Data Acquisition Software
(DATAQ Instruments Inc., Akron, Ohio, USA). Prior to recording, the
animals were habituated to the cardiovascular laboratory for 1 h. In
the morning 4–5 h before sacriﬁce, the animal was kept in an acrylic
tube with the tail free for placement of the sphygmomanometer and
blood pressure transducer for arterial pressure recording. Arterial
pressure was recorded for 5 min, and we obtained 5–6 SBP measure-
ments from each animal as references for analysis. Only 2K1C rats
with mean SBP of more than 150 mm Hg were included in this study.
Reproductive function
Male sexual behavior
Adult males had their sexual behaviors recorded 1–2 h after the
beginning of the dark phase. Each male rat was habituated to the
observation cage for 15 min before behavioral recording. After this
period, a sexually receptive femalewas introduced into the observation
cage, and the behavior was videotaped. The following parameters of the
male's behavior were recorded: latency to the ﬁrst intromission: time
(seconds) from the introduction of the female in the cage up to the
ﬁrst intromission; intromission frequency: the number of intromis-
sions; and the ejaculation latency: the time (seconds) from the ﬁrst
intromission of a series up to the ﬁrst ejaculation (Agmo, 1997). The
animals were videotaped until ejaculation or a maximum of 30 min if
no ejaculation was observed, and then the test was ﬁnished. The intro-
mission latency and intromission frequency were analyzed in the
ﬁrst 10 min of the 30 min recording period, because in most non-
hypertensive rats the recording session corresponded to 10 min. When
the frequency of intromissions was zero, the intromission latency was
considered to be 600 s. In rats that did not show intromission, the ejacu-
lation latency was considered to be 1800 s. The number of animals
showing intromissions and ejaculation was recorded (Breigeiron et al.,
2002, 2007).
Spermatogenesis
All rats had their right testis analyzed for measurement of the sper-
matid quotient (SQ) (number of spermatids×106) and epididymal
transit (ET) (transit time/days for the maturation of the sperm in the
epididymis). The testes were weighed, homogenized and sonicated in
8 mL of a T-X solution (NaCl .9% and Triton X-100 .05%). Aliquots of
100 mL of the homogenate were diluted in 900 mL of the T-X solution.
Homogenization-resistant testicular spermatids in the testes and sperm
in the caput/corpus epididymides and cauda epididymides were enu-
merated in Neubauer chambers. SQ was calculated by dividing the
total number of homogenization-resistant spermatids in testis by the
testicular parenchyma weight. Daily sperm production per testis was
determined by dividing the total number of homogenization-resistant
spermatids per testis by 6.1 days (the number of days of a seminiferous
cycle inwhich these spermatids are present) (Robb et al., 1978). Transit
times through the caput/corpus of epididymis and cauda of epididymis
were calculated by dividing the number of sperm within each of these
regions by the daily sperm production (Breigeiron et al., 2007).
Fig. 1. Systolic blood pressure (SBP; mm Hg) recordings 28 days after sham or 2K1C
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Enzyme-linked immunosorbent assay (ELISA)
Plasma concentration of Ang II (ng/mL) was measured by ligand
ELISA kits. We collected the animal's trunk blood in Eppendorf tubes
containing a cocktail of protease inhibitors phenylmethanesulfonyl
ﬂuoride and pepstatin (Sigma, USA). Blood samples were centrifuged
at 3000 rpm for 20 min at 4 °C. Each plasma sample was subsequently
transferred into a test tube and stored at−80 °C. Then, plasma Ang II
was measured using a commercial Angiotensin ll kit — EIA (Peninsula
Laboratories Inc., San Carlos, USA) according manufacturer's protocol.
The lower detection limit was 0.02–0.04 ng/mL.surgery under vehicle (V) or losartan (Los) treatment. The rats were divided into 4
groups: Sham+V (n=11), 2K1C+V (n=11), Sham+Los (n=11), and 2K1C+Los
(n=11). Values are means±SEM. There were signiﬁcant effects of clipping, losartan
treatment and the interaction between clipping and losartan treatment (ANOVA:
Pb0.0001). * Signiﬁcant difference between 2K1C+V and others groups (Bonferroni
test: Pb0.001).Radioimmunoassay (RIA)
Plasma concentrations of prolactin, testosterone and corticosterone
(ng/mL) were measured by RIA. Trunk blood was collected and centri-
fuged at 3000 rpm for 20 min at 4 °C. Each plasma sample was trans-
ferred into a test tube and stored at −80 °C for hormone assays.
Plasma prolactin was measured using speciﬁc kits provided by the
National Institute of Diabetes and Digestive and Kidney Diseases
(Baltimore, MD, USA). The lower detection limit was 0.09 ng/mL.
Plasma samples for testosterone concentration underwent an ex-
traction process with distilled ethylic ether. The testosterone con-
centration was performed using a tritiated hormone (1,2,6,7-3H
testosterone) acquired from New England Nuclear (USA) and a
testosterone standard and speciﬁc antibody acquired from Sigma
(USA). The separation of the free and bound fractions was performed
by incubation with dextran-coal. The detectable minimum doses
were 0.03 ng/mL. Plasma samples for corticosterone concentration
underwent an extraction process with distilled ethylic ether. Plasma
concentration of corticosteronewasmeasured using a corticosterone
standard and speciﬁc antibody acquired from Sigma (USA) and triti-
ated corticosterone from Amersham (USA). The detectable mini-
mum doses were 0.2 ng/mL. For each hormone, all samples were
run in duplicate in one assay.Statistical analysis
Data are expressed as mean±SEM, except for the latency data
and frequency data (sexual behavior) for which the median (inter-
quartile interval) was used. Sexual behavior data were analyzed by
the nonparametric Kruskal–Wallis test for comparison between the
main effects (renal artery clipping and losartan treatment) followed
by the Dunn's multiple range test for the comparison of the groups.
The percentage of animals that ejaculated was analyzed using the
chi-square test and data are expressed as percentage of rats in each
group. All other data were analyzed using two-way ANOVA for the
comparison of means and to determine whether there were effects
of renal artery clipping and losartan treatment or interaction be-
tween treatments, followed by Bonferroni's post hoc test pairwise
comparison of groups. In all cases, the level of signiﬁcance was set
at Pb0.05.Results
Systolic blood pressure
Fig. 1 shows a signiﬁcant increase in mean SBP in the 2K1C+V
group. Two-way ANOVA indicated that the clipping effect (F(1.43)=
30.52), losartan effect (F(1.43)=51.81), and interaction (F(1.43)=
35.01) were signiﬁcant (Pb0.0001). The 2K1C+V group showed a sig-
niﬁcant increase inmean SBP compared to the other groups (Bonferroni
test: Pb0.001) and losartan treatment prevented the increase in mean
SBP.Plasma hormones
Fig. 2 shows plasma Ang II, testosterone, prolactin and corticoste-
rone concentrations. Two-way ANOVA indicated that there was a sig-
niﬁcant increase in plasma Ang II by clipping effect: (F(1.43)=7.08;
Pb0.05) and losartan effect (F(1.43)=6.02; Pb0.05), but there was
no interaction. Thus, clipping increased plasma Ang II in 2K1C groups
and losartan treatment promoted an additional increase in Ang II
levels. By two-way ANOVA, there was a signiﬁcant effect of clipping
(F(1.38)=4.39; Pb0.05) and losartan treatment (F(1.38)=10.07;
Pb0.05) on plasma concentration of testosterone, indicating that
the 2K1C+V group presented lower plasma testosterone and losar-
tan treatment prevented this change. Plasma prolactin increased in
the 2K1C+V group. Two-way ANOVA indicated that there was a sig-
niﬁcant effect of clipping (F(1.43)=6.54; Pb0.05), but there was no
effect of losartan treatment and no interaction between the two treat-
ments. There was a signiﬁcant difference between the vehicle groups,
with the 2K1C+V group showing a signiﬁcantly higher prolactin
compared to the Sham+V group (Bonferroi test: Pb0.05). Plasma
corticosterone showed no signiﬁcant changes in any group.
Reproductive function
Male sexual behavior
Fig. 3 shows the effects of renovascular hypertension on the sexual
behavior of male rats 28 days after 2K1C or sham surgery. Kruskal–
Wallis indicated a signiﬁcant difference in the medians for the intro-
mission frequency (P=0.0001), intromission latency (P=0.0006)
and ejaculation latency (P=0.0007). Hypertensive rats (2K1C+V)
presented a reduced intromission frequency compared to the other
groups (Dunn's multiple comparison test: Pb0.05). Conversely, the
intromission latency increased in the 2K1C+V group when compared
to the Sham+V animals (Dunn's multiple comparison test: Pb0.001).
Ejaculation latency was increased in hypertensive rats compared to
the other groups (Dunn's multiple comparison test: Pb0.05). In the
2K1C+V group, only 64% of the animals ejaculated. Losartan treatment
prevented all changes in sexual behavior.
Spermatogenesis
Fig. 4 shows the spermatid quotient and epididymal transit in each
group. Two-way ANOVA indicated there was a signiﬁcant effect of
clipping (F(1.39)=17.56; Pb0.0002) for spermatid quotient analysis,
but no effect of losartan and no interaction. The spermatid quotient in
the 2K1C+V group was reduced compared to others (Bonferroni
test: Pb0.05), while groups treated with losartan did not show any
Fig. 2. Plasma concentrations of angiotensin II (Ang II), testosterone, prolactin, and cor-
ticosterone in male rats 28 days after sham or 2K1C surgery under vehicle or losartan
treatment. The rats were divided into 4 groups: Sham+V (n=11), 2K1C+V
(n=11), Sham+Los (n=11), and 2K1C+Los (n=11). Values are means±SEM.
A) Ang II: there were signiﬁcant effects of clipping and losartan treatment but no inter-
action between clipping and losartan treatment (ANOVA: Pb0.05). * Signiﬁcant differ-
ence between Sham+V and others groups. # Signiﬁcant difference between 2K1C+
Los and others groups (Bonferroni test: Pb0.05); B) testosterone: there was a signiﬁ-
cant effect of clipping and losartan treatment but no interaction between clipping and
losartan treatment (ANOVA: Pb0.05). * Signiﬁcant difference between 2K1C+V and
others group (Bonferroni test: Pb0.05); C) prolactin: there was a signiﬁcant effect of
clipping (ANOVA: Pb0.05) but no effect of losartan treatment and no interaction be-
tween clipping and losartan treatment. * Signiﬁcant difference between 2K1C+V and
Sham+V (Bonferroni test: Pb0.05); D) corticosterone: there were no signiﬁcant
effects.
Fig. 3. Sexual behavior of male rats 28 days after sham or 2K1C surgery under vehicle
or losartan treatment. The rats were divided into 4 groups: Sham+V (n=11), 2K1C+V
(n=11), Sham+Los (n=11), and 2K1C+Los (n=11). Values aremedians+interquartile
intervals for frequency and latency of data. The intromission recording session was 600 s,
and the ejaculation recording session was 1800 s. Kruskal–Wallis test indicated a signiﬁ-
cant difference in intomission frequency (P=0.0001), intromission latency (P=0.0006)
and ejaculation latency (P=0.0007). A) Intromission frequencywas signiﬁcantly reduced
in 2K1C+V compared to the other groups. * Signiﬁcant difference (Dunn's multiple com-
parison test: Pb0.05); B) intromission latency was signiﬁcantly increased in 2K1C+V
compared to Sham+V. * Signiﬁcant difference (Dunn's multiple comparison test:
Pb0.001); C) ejaculation latency was signiﬁcantly increased in 2K1C+V compared to
the other groups. * Signiﬁcant difference (Dunn's multiple comparison test: Pb0.05);
D) the percentage of 2K1C+V animals that ejaculated was signiﬁcantly diminished com-
pared to the other groups * Signiﬁcant difference (chi-square test: P=0.036).
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ping (F(1.39)=16.35; Pb0.0001), losartan treatment (F(1.39)=
23.31; Pb0.0003) and the interaction between clipping and losartan
treatment (F(1.39)=22.45; Pb0.0001) in epididymal transit analysis.
The epididymal transit increased in 2K1C+V group compared to the
others (Bonferroni test: Pb0.001).Discussion
This study shows that renovascular hypertension reduces sexual
behavior in male rats and impairs spermatogenesis by actions of
Ang II at the AT1 receptor. The results conﬁrm that the 2K1C model
induces hypertension, due to higher plasma Ang II levels, and indicate
an increase in plasma prolactin in contrast to the decrease in plasma
Fig. 4. Spermatid quotient and epididymal transit of male rats 28 days after sham or
2K1C surgery under vehicle or losartan treatment. The rats were divided into 4 groups:
Sham+V (n=10), 2K1C+V (n=10), Sham+Los (n=10), and 2K1C+Los (n=10).
Values are means±SEM. A) There was a signiﬁcant effect of clipping (ANOVA:
P=0.0002), but no effect of treatment and no interaction in the spermatid quotient
analysis. * Signiﬁcant difference in 2K1C+V compared to the other groups (Bonferroni
test: Pb0.05); B) there were signiﬁcant effects of clipping (ANOVA: Pb0.0001), losar-
tan treatment (ANOVA: Pb0.0003) and the interaction between clipping and losartan
treatment on epididymal transit (ANOVA: Pb0.0001). * Signiﬁcant difference in 2K1C+
V compared to the other groups (Bonferroni test: Pb0.001).
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sterone being observed. The effects of 2K1C on blood pressure, sexual
behavior, spermatogenesis, plasma testosterone and prolactin were
prevented by the systemic treatment with AT1 antagonist. These
results suggest that Ang II, acting through AT1 receptor, modulates
the reproductive dysfunction associated with renovascular hyperten-
sion and that treatmentwith AT1 antagonists improves sexual behavior
and spermatogenesis in hypertensive male rats.
In the 2K1C model, the hypertension is induced by unilateral renal
artery stenosis. The reduced renal perfusion pressure stimulates
increased renin synthesis, which increases Ang II production. Circu-
lating Ang II increases total peripheral resistance and raises blood
pressure (Pickering, 1989). Additionally, Ang II is present centrally
in neural sites that act on blood pressure control, such as the nucleus
of the solitary tract (Plunkett and Saavedra, 1985), subfornical organ
(Hendel and Collister, 2005), rostral ventrolateral medulla and para-
ventricular nucleus of the hypothalamus (Campos and Bergamaschi,
2006; Campos et al., 2011). Peripheral Ang II can traverse the circum-
ventricular organs and signal to central areas, contributing to the hy-
pertensive response (Campos, 2009; Maliszewska-Scislo et al., 2008).
The AT1 antagonist treatment conﬁrmed that renal artery clipping
requires this receptor to produce hypertension, as AT1 antagonist
prevented hypertension in the 2K1C+Los group. Furthermore,
losartan administration induced compensatory increases in circulat-
ing Ang ll in both groups (Sham+Los and 2K1C+Los). These data
are in accord with clinical studies in normotensive and hypertensive
patients, indicating the increased availability of circulating Ang II,
which cannot bind to blocked AT1 receptor (Christen et al., 1991;
Mazzolai et al., 1999). In addition, the AT1 receptor antagonism
disrupts the negative feedback of Ang II on renin-secreting granular
cells, leading to increases in reactive plasma renin activity and the
concentration of circulating Ang II.Our results show that renovascular hypertension in male rats
inhibits sexual behavior and spermatogenesis, increases plasma pro-
lactin and reduces plasma testosterone in agreement with previous
data from our laboratory using a Ca++ channel blocker (Breigeiron
et al., 2007). However, in that previous study, treatment with nifedi-
pine prevented only the reduction of sexual behavior and the increase
of plasma prolactin but did not alter the reduction of plasma testoster-
one or spermatogenesis of 2K1C rats. The present study shows that AT1
receptor modulates both behavioral and endocrine parameters of
reproductive function during renovascular hypertension. Comparing
the effects of nifedipine and losartan treatment on reproduction of
hypertensive male rats, we propose that the spermatogenesis dys-
function was caused by the increase of Ang II, induced by renal artery
clipping, associated with the reduction of plasma testosterone. This
effect might be attributable to activation of AT1 receptors, since losar-
tan treatment prevented changes in spermatogenesis and testosterone
reduction. Probably, impairment on sexual behavior and prolactin
increase are mainly associated with the effects of hypertension, since
both drugs reduced blood pressure and prevented the decrease of
sexual behavior and increased prolactin in 2K1C rats.
In 2K1C rats, it is possible that increased Ang II acts on Leydig cells
to inhibit the stimulation of testosterone production by LH. The stim-
ulation of Ang II receptors in Leydig cells inhibits the ability of LH to
stimulate testosterone production through inhibition of the cAMP
pathway (Khanum and Dufau, 1988). This effect seems to be mediated
by AT1 receptor because losartan treatment in 2K1C rats prevented
the plasma testosterone reduction. Testosterone is essential for the
initiation and maintenance of spermatogenesis because somatic Sertoli
cells, Leydig cells and peritubular cells have active androgen recep-
tors (Welsh et al., 2009). The reduction of plasma testosterone can
damage the nutrition and development of spermatic cells. In fact, hy-
pertensive rats presented a reduced spermatid quotient, which can
lead to a deﬁcit in daily sperm production. The increased epididymal
transit suggests impairment in maturation and storage capacity of
epididymal sperm. Additionally, the presence of functional Ang II recep-
tors in rat testis and epididymis supports its involvement in gonad
function (Grove and Speth, 1989; KhanumandDufau, 1988). Seminifer-
ous tubule contraction is important for spermatogenesis regulation and
testicular sperm output. In vitro studies have shown that Ang II, via the
AT1 receptor, increases intracellular calcium, cell growth and contrac-
tion in rat peritubular myoid cells (Rossi et al., 2002). Losartan treat-
ment prevented the reduction in the spermatid quotient and the
increase in epididymal transit caused by 2K1C, conﬁrming the partic-
ipation of Ang II and AT1 receptor in the regulation of spermato-
genesis. We suggest that the combined effects of increased Ang II and
reduced testosterone in our 2K1C model contribute to impaired
spermatogenesis.
In addition, prolactin seems to be involved in spermatogenesis
regulation. Quantitative RT-PCR and in situ hybridization have detected
the expression of prolactin in Leydig cells and in spermatogonia, there-
by suggesting that prolactin participates in mouse spermiogenesis and
spermatogenesis (Ishida et al., 2010). Therefore, hyperprolactinemia
alters the mechanism of chromatin condensation during rat spermio-
genesis, causing a decrease in spermatozoid quality and inducing infer-
tility (Gill-Sharma, 2009). Prolactin can control testicular function in
other ways: acting directly on the pituitary, to inhibit LH and FSH syn-
thesis (Bartke et al., 1977), or on the testes, to regulate testosterone
synthesis induced by LH (Zipf et al., 1978). Therefore, we propose
that increased plasma prolactin can contribute to delaying spermatid
maturation in hypertensive rats. However, prolactin does not appear
to be crucial in spermatogenesis, as our previous study showed that
nifedipine administration normalizes plasma prolactin but does not
alter spermatogenesis impairment or plasma testosterone reduction.
In addition, it is important to consider the participation of vascular
damage in the decrease of spermatogenesis in hypertensive rats.
Studies in spontaneously hypertensive rats suggest that the decline
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involving the spermatid number reduction (Itoh et al., 1995).
The plasma prolactin increase in the 2K1C+V group was probably
due to the predominantly stimulatory effect of Ang II on the pituitary,
involving the AT1 receptor, because the 2K1C+Los group showed no
signiﬁcant change in plasma prolactin. There is evidence that Ang II
acts directly on the lactotropes of the anterior pituitary, stimulating
prolactin release, an effect mediated by the AT1 receptor (Aguilera
et al., 1982; Steele and Myers, 1990). The combined increases in plas-
ma Ang II and prolactin could explain the great impairment of sexual
behavior in 2K1C animals because clinical and experimental data
indicate that prolactin is involved in the regulation of reproduction
function (Drago, 1984; Drago and Lissandrello, 2000; Gill-Sharma,
2009). Prolactin receptor expression in the medial preoptic area
(MPOA) and arcuate nucleus conﬁrm the hypothesis that prolactin
participates in reproductive function (Kokay et al., 2011). Chronic
hyperprolactinemia is related to sexual dysfunction in humans and
rats (Corona et al., 2007; Cruz-Casallas et al., 1999), whereas the
prolonged stimulation of central dopamine transmission can lead to
hyposensitivity or downregulation of dopamine receptor systems
(Mohankumar et al., 1997), causing sexual dysfunction.
We observed that hypertensive rats presented a sexual behavior
inhibition, as represented by a reduction of the intromission frequen-
cy and greater intromission and ejaculation latencies. In fact, hyper-
tensive animals showed a decrease in the ejaculation behavior.
Intromission and ejaculation abilities are indicators of erectile
function in rats (Chan et al., 1999; Keaton and Clark, 1998). Losartan
treatment prevented all changes in sexual behavior. These data indi-
cate an association between plasma Ang ll increases and the impair-
ment of erectile function in hypertensive rats, as mediated through
AT1 receptor. The renin–angiotensin system affects reproductive
function by acting at central and peripheral levels. Actions of Ang II
in the central nervous system can be exerted by locally produced
Ang II, as well as by peripheral Ang II, through the circumventricular
organs (Mangiapane and Simpson, 1980; Vieira et al., 2010). The
presence of Ang II and its receptors in brain areas that exert control
over reproductive function, such as MPOA and the medial amygdaloid
nucleus (MeA) (Von Bohlen und Halbach and Albrecht, 1998a,
1998b), support the participation of Ang II in sexual behavior. Along
these lines, Ang II inhibits sexual behavior when injected into the
brain (Clark, 1988), which is an effect that involves AT1 and AT2
receptors (Breigeiron et al., 2002). It is important to consider that
the pathogenesis of sexual dysfunction associated with hypertension
may be multifactorial. Impaired penile arterial function has been
observed in impotent patients with hypertension (Kochar et al.,
1999; Müller et al., 1991). Ang II is physiologically involved in the
initiation of penile detumescence in men (Becker et al., 2001), and
therapies using AT1 receptor antagonists have been associated
with the ability to maintain adequate erections (Della Chiesa et al.,
2003). In contrast, some classes of antihypertensive drugs such as
diuretics or β-blockers can interfere with sexual function, causing
erectile dysfunction, decrease libido and impaired ejaculation in
patients (Ferrario and Levy, 2002).
Our data show no changes in plasma corticosterone in hypertensive
rats, despite increases of plasma Ang ll. This result is in agreement with
ﬁndings in which systemic treatment of rats with exogenous angioten-
sin does not change the basal level of corticosterone (Müller et al., 2007).
The results of our study suggest the activation of compensatory mecha-
nisms in response to the higher plasma Ang II, thereby preventing
increases in plasma corticosterone in 2K1C animals. We hypothesized
that Ang II would stimulate the paraventricular nucleus of the hypothal-
amus to synthesize corticotropin-releasing factor, but an increase in
corticosterone would be prevented by feedback inhibition in the
hypothalamo-pituitary-adrenal (HPA) axis, which has receptors for
Ang II (Von Bohlen und Halbach and Albrecht, 1998a, 1998b). In this
case, areas such as the hippocampus would inhibit the HPA axis andconsequently prevent the increase in corticosterone. This knowledge
is consistent with recent study that shows, the action of the renin–
angiotensin systemon thehippocampus of hypertensive ratsmediating
cognitive responses (Pelisch et al., 2011).
We conclude that renovascular hypertension inhibits reproductive
function in male rats, and this effect is mediated in part by Ang II acting
through AT1 receptor. Moreover, the effects of the increased circulating
Ang II on plasma prolactin and testosterone seem to contribute to
the sexual and spermatogenic dysfunctions in hypertensive rats. The
major ﬁnding in this study was the evidence that the AT1 receptor pro-
motes a plasma testosterone reduction and impairs spermatogenesis in
renovascular hypertensive rats.
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